Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, drinking and opioid use disorders and addiction.

Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on ...

A vast majority of American adults say they have consumed alcohol at some point — yet experts warn that alcoholic beverages could be a "gateway drug" to more harmful substances. More than 84% of ...

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some ...

The interactive nature of video games makes them uniquely suited to help people understand and recover from addiction.

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be ...

Nearly 50 million over the age of 12 reportedly have substance use disorders, which can include addictions to alcohol or drugs. Other issues that affect millions - such as gambling, shopping, gaming, ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce drug- and alcohol-related overdoses and deaths ...

A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.

HONOLULU (KHON2) — January is Substance Use Disorder Treatment Month, which is designed to raise awareness about those suffering with substance use. Addiction is a disease, and leaders at the Hawaiʻi ...

The Douglas County Commission chose to allocate nearly 71% of its funding from a pool of money designated for preventing, treating, and mitigating substance use disorders on Wednesday. Last December, ...